Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CRISPR Systems for COVID-19 Diagnosis.
Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, Davaran S, Chauhan SC, Danafar H, Kaboli S, Nosrati H, Yallapu MM, Conde J. Rahimi H, et al. Among authors: barsbay m. ACS Sens. 2021 Apr 23;6(4):1430-1445. doi: 10.1021/acssensors.0c02312. Epub 2021 Jan 27. ACS Sens. 2021. PMID: 33502175 Review.
Curcumin delivery by modified biosourced carbon-based nanoparticles.
Danafar H, Salehiabar M, Barsbay M, Rahimi H, Ghaffarlou M, Arbabi Zaboli K, Faghfoori MH, Kaboli S, Nosrati H, Faghfoori Z. Danafar H, et al. Among authors: barsbay m. Nanomedicine (Lond). 2022 Jan;17(2):95-105. doi: 10.2217/nnm-2021-0225. Epub 2022 Jan 10. Nanomedicine (Lond). 2022. PMID: 35000461
Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer.
Nosrati H, Ghaffarlou M, Salehiabar M, Mousazadeh N, Abhari F, Barsbay M, Ertas YN, Rashidzadeh H, Mohammadi A, Nasehi L, Rezaeejam H, Davaran S, Ramazani A, Conde J, Danafar H. Nosrati H, et al. Among authors: barsbay m. Biomater Adv. 2022 Sep;140:213090. doi: 10.1016/j.bioadv.2022.213090. Epub 2022 Aug 22. Biomater Adv. 2022. PMID: 36027669
Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy.
Salehiabar M, Ghaffarlou M, Mohammadi A, Mousazadeh N, Rahimi H, Abhari F, Rashidzadeh H, Nasehi L, Rezaeejam H, Barsbay M, Ertas YN, Nosrati H, Kavetskyy T, Danafar H. Salehiabar M, et al. Among authors: barsbay m. J Control Release. 2023 Jan;353:850-863. doi: 10.1016/j.jconrel.2022.12.004. Epub 2022 Dec 17. J Control Release. 2023. PMID: 36493951
23 results